Site Expansion - Regional Round-Up: Florida
Regional Round-Up: Florida
Key cities and populations
Miami-Ft. Lauderdale-West Palm Beach: 5,255,805; Tampa-St. Petersburg-Clearwater: 2,535,439; Orlando: 1,829,219; Jacksonville: 1,185,201
Targeted industries
Life sciences, information technology, aviation/aerospace, homeland security/defense, financial/professional services; visit
Biopharm employment
4,177 (NAICS code: 3254 — Pharm. & Medicine Mfg.)
Academia affiliated with biopharm industry
Florida Agricultural & Mechanical University, Florida Atlantic University, Florida International University, Florida State University, University of Florida, University of South Florida
Primary business strengths
Favorable business tax climate; no state personal income tax; affordable, diverse, and highly-skilled workforce; worldwide connectivity; excellent quality of life; visit
Tax and other incentives
Targeted industry incentives: qualified target industry tax refund, high impact performance incentive grant, qualified defense contractor tax refund, capital investment tax credit; Workforce training incentives: quick response training incentives, incumbent worker training program, economic development transportation fund; special opportunity incentives: rural incentives, urban incentives, enterprise zone incentives, brownfield incentives; visit
BioClusters
Sid Martin Biotechnology Development Incubator
State commitment to biopharm industry and future plans for its growth
Florida provided a large and unique incentive package (state & local) totaling $510 million to bring The Scripps Research Institute to Florida. The Scripps Research Institute, one of the world?s largest biomedical research institutes, has recently chosen Florida as the location for its second major research facility. It is estimated that an additional 6,500 direct and indirect jobs will be created as a result of the industry clustering that is expected to take place surrounding the Scripps Florida nucleus.
State- and regional-level contacts
BioFlorida
Articles in this issue
Site Expansion - Regional Roundup: Georgia
Site Expansion - Regional Round-Up: Florida
A Protocol for Trademark Protection
Technology Licensing — From First Steps to Executing a Plan
Integrating QSIT into Quality Plans
Big Pharma And Investors Eye Australian Bio-Innovation Powerhouse
Correlating the Results from Chemistry Analyzers
Regulatory Beat: FDA: Manufacturing Innovation Can Boost R&D
Final Word: PEGylation — A "Sunset" Technology?
After the Consent Decree — An Uphill Battle for Affected Companies
Wall Street Gets Personal
Oral Delivery And Recombinant Production Of Peptide Hormones
